Physician profile
Patrick John Kendell
NPI 1225324973
$4,425.64
in general payments reported to CMS, 2019-2025
47 companies · $770 in 2025
The $770 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $521 · 2021: $804 · 2022: $656 · 2023: $528 · 2024: $547 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,845.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $540.56 | 2019-2025 | Evenity, Repatha, Otezla |
| Abbvie INC. | $469.61 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $347.71 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Lilly USA, LLC | $344.26 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $338.24 | 2019-2025 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $319.08 | 2019-2025 | Arexvy, Shingrix, Bexsero |
| E.R. Squibb & Sons, L.L.C. | $218.31 | 2019-2022 | |
| Amarin Pharma, INC. | $176.06 | 2020-2022 | |
| Pfizer INC. | $146.54 | 2019-2024 | |
| Astellas Pharma US INC | $135.35 | 2020-2024 | Veozah |
| Dynavax Technologies Corporation | $132.46 | 2019-2025 | Heplisav-B |
| Janssen Pharmaceuticals, INC | $89.18 | 2019-2024 | Spravato |
| Sanofi-Aventis U.S. LLC | $86.85 | 2019-2025 | |
| Arbor Pharmaceuticals, INC. | $70.99 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $57.82 | 2022-2023 | Quviviq |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kendell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.